NextCell Pharma AB (STO:NXTCL)

NextCell Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is September - August.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 31, 2025	Aug 31, 2024	Aug 31, 2023	Aug 31, 2022	Aug 31, 2021	Aug 31, 2020
Cash & Equivalents	16.71	46.79	50.03	97.12	139.17	21.96
Cash & Short-Term Investments	16.71	46.79	50.03	97.12	139.17	21.96
Cash Growth	-19.65%	-6.47%	-48.49%	-30.22%	533.78%	9.09%
Accounts Receivable	2.46	1.67	2.35	1.78	1.39	0.82
Other Receivables	1.16	1.45	1.24	0.93	0.31	0.45
Receivables	3.62	3.12	3.58	2.71	1.7	1.27
Inventory	0.55	0.55	0.79	0.77	-	-
Prepaid Expenses	10.11	10.17	12.87	6.16	5.61	2.8
Other Current Assets	-0	0.05	0	-	-	-0
Total Current Assets	30.99	60.67	67.27	106.75	146.48	26.03
Property, Plant & Equipment	13.21	12.66	13.55	9.9	2.9	2.61
Long-Term Investments	6.87	6.92	6.87	6.87	5.11	-
Other Long-Term Assets	1.14	1.03	1.13	1.13	1.13	1.13
Total Assets	52.21	81.29	88.83	124.66	155.63	29.77
Accounts Payable	3.83	6.16	0.89	1.92	1.28	0.48
Accrued Expenses	2.27	2.49	7.65	4.16	0.59	0.66
Current Unearned Revenue	-	0.25	0.2	-	-	0.06
Other Current Liabilities	0.69	0.98	1.35	0.85	2.08	0.97
Total Current Liabilities	6.79	9.87	10.08	6.93	3.96	2.17
Long-Term Unearned Revenue	4.33	3.82	3.02	2.18	1.58	1.04
Other Long-Term Liabilities	-	-0	-0	-	-	0.34
Total Liabilities	11.12	13.69	13.1	9.12	5.53	3.56
Common Stock	14.98	14.98	7.05	7.05	7.05	4.8
Additional Paid-In Capital	222.33	222.33	196.43	196.43	196.43	50.25
Retained Earnings	-196.22	-169.71	-127.75	-87.94	-53.38	-28.83
Shareholders' Equity	41.09	67.6	75.73	115.54	150.09	26.22
Total Liabilities & Equity	52.21	81.29	88.83	124.66	155.63	29.77
Net Cash (Debt)	16.71	46.79	50.03	97.12	139.17	21.96
Net Cash Growth	-19.65%	-6.47%	-48.49%	-30.22%	533.78%	9.09%
Net Cash Per Share	0.24	1.15	1.46	2.82	4.58	1.11
Filing Date Shares Outstanding	111.39	73.09	34.38	34.38	34.38	23.4
Total Common Shares Outstanding	73.09	73.09	34.38	34.38	34.38	23.4
Working Capital	24.2	50.8	57.19	99.82	142.52	23.86
Book Value Per Share	0.56	0.92	2.20	3.36	4.37	1.12
Tangible Book Value	41.09	67.6	75.73	115.54	150.09	26.22
Tangible Book Value Per Share	0.56	0.92	2.20	3.36	4.37	1.12
Machinery	-	16.04	5.22	5.15	5.25	4.53
Construction In Progress	-	-	11.59	7.56	-	-

Updated May 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.